This article is an erratum on:
Follow Your Nose: A Key Clue to Understanding and Treating COVID-19
Frontiers Production Office*An Erratum on
Follow Your Nose: A Key Clue to Understanding and Treating COVID-19
by Edwards, C., Klekot, O., Halugan, L. and Korchev, Y. (2021). Front. Endocrinol. 12:747744. doi: 10.3389/fendo.2021.747744
Owing to a production error, several dependent variables were omitted from the part of Table 2 that pertains to Study 1 in the article as originally published. The variables in question are mean diastolic blood pressure, breath rate, C-reactive protein concentration, D-dimer concentration, fasting glucose concentration and plasma potassium concentration. The complete part of Table 2 that pertains to Study 1 is presented here.
TABLE 2
Table 2 Study 1. Repeated measures analysis comparing changes in variables from baseline to 5 days treatment (T1).
The publisher apologizes for this error. The original article has been updated.
Keywords: COVID-19, mineralocorticoid receptor, spironolactone and dexamethasone, ATP - adenosine triphosphate, anosmia and ageusia
Citation: Frontiers Production Office (2021) Erratum: Follow Your Nose: A Key Clue to Understanding and Treating COVID-19. Front. Endocrinol. 12:830164. doi: 10.3389/fendo.2021.830164
Received: 06 December 2021; Accepted: 06 December 2021;
Published: 16 December 2021.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2021 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, production.office@frontiersin.org